Related Experiment Videos
[Urogenital rhabdomyosarcoma in children: analysis of 39 cases]
Insights
This study on urogenital rhabdomyosarcoma found that conservative surgery combined with chemotherapy offers a justified treatment approach. Many young patients achieved long-term survival and organ preservation, highlighting treatment advancements.
Area of Science:
- Pediatric Oncology
- Urologic Oncology
- Surgical Oncology
Context:
- Urogenital rhabdomyosarcoma is a rare and aggressive pediatric malignancy.
- Historically, treatment involved radical surgery with significant morbidity.
- This study reviews outcomes for patients treated between 1967 and 1992.
Purpose:
- To evaluate the efficacy of treatment strategies for urogenital rhabdomyosarcoma.
- To assess survival rates and organ preservation in affected children.
- To determine the justification for conservative surgical approaches combined with chemotherapy.
Summary:
- 39 patients with urogenital rhabdomyosarcoma (ages 4 months–14 years) were analyzed.
- Most tumors were located in the bladder/prostate (26/39).
- 15 survivors (65%) were observed, with 13 tumor-free for over 4 years; organ preservation was achieved in 6 patients.
Impact:
- Conservative surgery and chemotherapy demonstrate a justified approach for urogenital rhabdomyosarcoma.
- Improved outcomes including long-term survival and functional organ preservation are achievable.
- This supports evolving treatment paradigms towards less invasive, multimodal therapies in pediatric oncology.
Abstract:
From 1967 to 1992, 39 patients with urogenital rhabdomyosarcoma were admitted to our hospital. Of them 30 were male and 8 female and their age ranged from 4 months to 14 years (32 were less than 5 years). Primary tumor was located in bladder or/and prostate in 26, paratesticule 9, vagina 3, and penis 1. Among the 31 patients receiving treatment, 23 were followed up. There were 15 (65%) survivors, including 13 who were free from tumor for over 4 years. The eldest two patients were 20 and 21 years of age. Two patients with vaginal tumor and 4 with bladder tumor preserved their organs with normal function. Biopsy were done only in 8 patients. In recent years, conservative surgery combined with chemotherapy for urogenital rhabdomyosarcoma has been justified.